Medline price target raised to $53 from $48 at Mizuho

Mizuho analyst Steven Valiquette raised the firm’s price target on Medline (MDLN) to $53 from $48 and keeps an Outperform rating on the shares. The firm gives the shares a higher multiple post the earnings report.